Status:
COMPLETED
Maternal Adversity, Vulnerability and Neurodevelopment
Lead Sponsor:
Douglas Mental Health University Institute
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
The JPB Foundation
Conditions:
Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)
Infant Development
Eligibility:
All Genders
3-6 years
Brief Summary
Maternal Adversity Vulnerability and Neurodevelopment (MAVAN) project is a prospective community-based, pregnancy and birth cohort of Canadian mother-child dyads. The main objective of MAVAN project i...
Detailed Description
In 2003 the Canadian Institutes of Health Research (CIHR) funded an ambitious and internationally unique study on the development of individual differences in vulnerability for mental illness. Increas...
Eligibility Criteria
Inclusion
- Pregnant women recruited when they attending antenatal care clinics at the time of routine ultrasound or through advertisements at hospitals (usually at 13 to 20 weeks' gestation). Women were included in the study if they were 18 years of age or older, and fluent in either English or French. Only babies born at 37 weeks or later and above 2000 g were included in the MAVAN cohort.
Exclusion
- Exclusion criteria included serious obstetric complications during the pregnancy or delivery of the child, extremely low birth weight, prematurity (less than 37 weeks of gestation), or any congenital diseases.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
630 Patients enrolled
Trial Details
Trial ID
NCT03434457
Start Date
October 1 2003
End Date
December 1 2017
Last Update
May 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Douglas Mental Health University Institute
Verdun, Quebec, Canada, H4H 1R3